🔴 RCKT is trading 6.9% down today, extending a pullback amid broader market weakness

RCKT is trading at $3.03 (6.9% down), extending a pullback from gains seen earlier in June.

• The move appears to be driven by continued volatility following prior FDA-related news and a wider Q1 loss earlier this quarter, as there are no fresh company-specific headlines today.
• The decline comes against a generally weak broader market backdrop.